Mixed Monoclonal Antibody Cocktail for Cancer Therapy

A blended preparation of multiple monoclonal antibodies (MABs) such as trastuzumab and pertuzumab for targeted cancer immunotherapy. Classified under HTS 3002.14.00 as mixed immunological products not in measured doses or retail packaging, involving peptides and proteins regulating immunological processes.

Import Duty Rates by Country of Origin

Origin CountryMFN RateCh.99 SurchargesTotal Effective Rate
🇨🇳ChinaFree—Free
🇲🇽MexicoFree—Free
🇨🇦CanadaFree—Free
🇩🇪GermanyFree—Free
🇯🇵JapanFree—Free

More Specific Codes

This product may fall under a more specific subheading:

Alternative Classifications

This product could be classified differently depending on its characteristics or intended use.

3002Same rate: Free

If consisting of a single immunological product

Unmixed immunological products like single MABs fall under 3002.11.00 per chapter note treating single peptides/proteins separately.

3002.90Higher: 10% vs Free

If put up in measured doses for retail sale

Retail-packaged immunological products shift to 3002.90, as 3002.14 excludes forms for retail sale.

2937.90Higher: 10% vs Free

If hormones rather than immunological peptides

Certain biotech products classified as hormones under Chapter 29 if not directly regulating immunological processes.

Not sure which classification is right?

Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.

Import Tips & Compliance

• Verify product is mixed (e.g

• multiple MABs combined) and not in measured doses via Certificate of Analysis to confirm 3002.14.00

• Provide biotech process documentation and immunological activity proof; avoid retail packing to prevent reclassification